Extended NO analysis applied to patients with COPD, allergic asthma and allergic rhinitis

被引:113
作者
Högman, M [1 ]
Holmkvist, T [1 ]
Wegener, T [1 ]
Emtner, M [1 ]
Andersson, M [1 ]
Hedenström, H [1 ]
Meriläinen, P [1 ]
机构
[1] Univ Uppsala, Dept Med Sci, SE-75123 Uppsala, Sweden
关键词
nitric oxide; asthma; allergic rhinitis; smoker; COPD; airway inflammation; method;
D O I
10.1053/rmed.2001.1204
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The recommended method to measure exhaled nitric oxide (NO) cannot reveal the source of NO production. We applied a model based on the classical Fick's first law of diffusion to partition NO in the lungs. The aim was to develop a simple and robust solution algorithm with a data quality control feature, and apply it to patients with known alterations in exhaled NO. Subjects with allergic rhinitis, allergic asthma, chronic obstructive pulmonary disease (COPD) smokers and controls were investigated. NO was measured at three expiratory flow rates. An iteration method was developed to partition NO. The airway tissue content of NO was increased in asthma, 144 +/- 80 ppb (P = 0(.)04) and decreased in smokers, 56 +/- 36 ppb (P = 0(.)02). There was no difference between subjects with rhinitis, 98 +/- 40 ppb and controls, 98 +/- 44 ppb. The airway transfer rate was increased in allergic asthma and allergic rhinithis, 12 +/- 4 vs. 12 +/- 5 ml sec(-1), compared to controls, 8 +/- 2 ml sec(-1) (P < 0(.)001). The alveolar levels were no different from controls, 2 +/- 1 ppb. In COPD the alveolar levels were increased, 4 +/- 2 ppb (P < 0(.)001). Extended NO analysis reveals from where in the respiratory system NO is generated. Hence, this new test can be added to the tools the physician has for the diagnosis and treatment of patients with respiratory disorders. (C) 2001 Harcourt Publishers Ltd.
引用
收藏
页码:24 / 30
页数:7
相关论文
共 18 条
  • [1] ALVING K, 1993, EUR RESPIR J, V6, P1368
  • [2] FEEDBACK INHIBITION OF NITRIC-OXIDE SYNTHASE ACTIVITY BY NITRIC-OXIDE
    ASSREUY, J
    CUNHA, FQ
    LIEW, FY
    MONCADA, S
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1993, 108 (03) : 833 - 837
  • [3] STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT
    BLAND, JM
    ALTMAN, DG
    [J]. LANCET, 1986, 1 (8476) : 307 - 310
  • [4] Endogenous nitric oxide in patients with stable COPD: correlates with severity of disease
    Clini, E
    Bianchi, L
    Pagani, M
    Ambrosino, N
    [J]. THORAX, 1998, 53 (10) : 881 - 883
  • [5] Increased exhaled nitric oxide in patients with stable chronic obstructive pulmonary disease
    Corradi, M
    Majori, M
    Cacciani, GC
    Consigli, GF
    de'Munari, E
    Pesci, A
    [J]. THORAX, 1999, 54 (07) : 572 - 575
  • [6] FICK AE, 1856, MED PHYSIK
  • [7] The oxyhemoglobin reaction of nitric oxide
    Gow, AJ
    Luchsinger, BP
    Pawloski, JR
    Singel, DJ
    Stamler, JS
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (16) : 9027 - 9032
  • [8] ENDOGENOUS NITRIC-OXIDE IS PRESENT IN THE EXHALED AIR OF RABBITS, GUINEA-PIGS AND HUMANS
    GUSTAFSSON, LE
    LEONE, AM
    PERSSON, MG
    WIKLUND, NP
    MONCADA, S
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1991, 181 (02) : 852 - 857
  • [9] Exhaled and nasal NO levels in allergic rhinitis: relation to sensitization, pollen season and bronchial hyperresponsiveness
    Henriksen, AH
    Sue-Chu, M
    Holmen, TL
    Langhammer, A
    Bjermer, L
    [J]. EUROPEAN RESPIRATORY JOURNAL, 1999, 13 (02) : 301 - 306
  • [10] Exhaled nitric oxide partitioned into alveolar, lower airways and nasal contributions
    Högman, M
    Drca, N
    Ehrstedt, C
    Meriläinen, P
    [J]. RESPIRATORY MEDICINE, 2000, 94 (10) : 985 - 991